Respiratory Infections News

Moderna said Wednesday that its messenger RNA-based combination vaccine against influenza and COVID-19 elicited neutralizing antibody levels that were as high — or higher — than existing vaccines in a phase 1/2 trial.

The FDA on Tuesday authorized Novavax’s updated COVID-19 vaccine for emergency use in adolescents and adults, giving the country a third vaccine option heading into the fall and winter respiratory diseases season.

Among patients with cystic fibrosis, increases in sulfate and specific metals in water raised the odds for nontuberculosis mycobacterial infections, according to results published in Environmental Epidemiology.

Influenza poses significant health and socioeconomic threats despite cases drastically dropping during the COVID-19 pandemic.

SARS-CoV-2 infection accounted for roughly one in six cases of sepsis at five Massachusetts hospitals during the first 33 months of the COVID-19 pandemic, according to findings from a large study of more than 430,000 patient encounters.

As experts raise awareness of the evidence supporting shorter antibiotic therapy for some conditions and the benefits of oral vs. IV-only therapy for others, we wanted to know: What is another ID dogma that should be reevaluated?

Despite experts warning of the dangers of influenza, COVID-19, respiratory syncytial virus and pneumococcal disease this fall and winter, survey data shows that many U.S. adults underestimate the seriousness of these infections.

The CDC last week recommended Pfizer’s respiratory syncytial virus vaccine for pregnant people to protect newborns from severe RSV illness.

Access to COVID-19 therapeutic drugs in U.S. counties decreased if the county had an increased population of Black individuals, according to a research letter published in JAMA Network Open.

In 2022, more than one in 20 adults in the United States reported ever having long COVID, with women more likely than men to report lingering COVID-19 symptoms months after infection, a CDC survey found.